Outlook on the Specialty Generics Global Market to 2026 – by Region, Route of Administration, Indication and Distribution Channel

NEXT STORY
Healthy Extracts Inc. (OTCQB: HYEX) Announces the Addition of Dr. Joel Kahn, Renowned Integrative Cardiologist, to Its Medical Board
PREV STORY
Corbus Pharmaceuticals Announces Completion of Enrollment in NIH-Sponsored Phase 2 Study of Lenabasum for Treatment of Systemic Lupus Erythematosus (SLE)
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

NeuBase Therapeutics Announces Appointment of Curt Bradshaw, Ph.D. as Chief Scientific Officer

author_avatar
NASDAQ Market News

Global Clinical Trials Trends and Recent Advancements Report 2019: Year Over Year Clinical Trials in Top 10 Therapy Areas, 2007-2018

Dublin, Jan. 30, 2019 (GLOBE NEWSWIRE) -- The "Global Clinical Trials - Current Trends ...

author_avatar
NASDAQ Market News

BioNTech erweitert klinisches Onkologie-Portfolio: Erster Patient in Phase 2-Studie mit individualisierter mRNA-basierter Immuntherapie BNT122 gegen Darmkrebs behandelt

author_avatar
NASDAQ Market News